<?xml version="1.0" encoding="UTF-8"?>
<ref id="B202">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sun</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Cunningham</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Wasserman</surname>
    <given-names>S. S.</given-names>
   </name>
   <name>
    <surname>Perry</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Putnak</surname>
    <given-names>J. R.</given-names>
   </name>
   <name>
    <surname>Eckels</surname>
    <given-names>K. H.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2009</year>). 
  <article-title>Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naive adults</article-title>. 
  <source>Hum. Vaccin.</source>
  <volume>5</volume>, 
  <fpage>33</fpage>â€“
  <lpage>40</lpage>. 
  <pub-id pub-id-type="doi">10.4161/hv.5.1.6348</pub-id>
  <?supplied-pmid 18670195?>
  <pub-id pub-id-type="pmid">18670195</pub-id>
 </mixed-citation>
</ref>
